<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Palme PR</submitter><funding>German Research Foundation</funding><funding>German Research Foundation (DFG)</funding><funding>Mukoviszidose Institut gGmbH (Bonn, Germany), the research and development arm of the German Cystic Fibrosis Association Mukoviszidose e. V.</funding><pagination>375-382</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11299207</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>80(Pt 8)</volume><pubmed_abstract>The title compound, 3-[(benzo-1,3-dioxol-5-yl)amino]-4-methoxycyclobut-3-ene-1,2-dione, C&lt;sub>12&lt;/sub>H&lt;sub>9&lt;/sub>NO&lt;sub>5&lt;/sub> (3), is a precursor to an antimycobacterial squaramide. Block-shaped crystals of a monoclinic form (3-I, space group P2&lt;sub>1&lt;/sub>/c, Z = 8, Z' = 2) and needle-shaped crystals of a triclinic form (3-II, space group P-1, Z = 4, Z' = 2) were found to crystallize concomitantly. In both crystal forms, R&lt;sub>2&lt;/sub>&lt;sup>2&lt;/sup>(10) dimers assemble through N-H...O=C hydrogen bonds. These dimers are formed from crystallographically unique molecules in 3-I, but exhibit crystallographic C&lt;sub>i&lt;/sub> symmetry in 3-II. Twinning by pseudomerohedry was encountered in the crystals of 3-II. The conformations of 3 in the solid forms 3-I and 3-II are different from one another</pubmed_abstract><journal>Acta crystallographica. Section C, Structural chemistry</journal><pubmed_title>3-[(Benzo-1,3-dioxol-5-yl)amino]-4-methoxycyclobut-3-ene-1,2-dione: polymorphism and twinning of a precursor to an antimycobacterial squaramide.</pubmed_title><pmcid>PMC11299207</pmcid><funding_grant_id>2202</funding_grant_id><funding_grant_id>432291016</funding_grant_id><pubmed_authors>Goddard R</pubmed_authors><pubmed_authors>Imming P</pubmed_authors><pubmed_authors>Palme PR</pubmed_authors><pubmed_authors>Seidel RW</pubmed_authors><pubmed_authors>Richter A</pubmed_authors></additional><is_claimable>false</is_claimable><name>3-[(Benzo-1,3-dioxol-5-yl)amino]-4-methoxycyclobut-3-ene-1,2-dione: polymorphism and twinning of a precursor to an antimycobacterial squaramide.</name><description>The title compound, 3-[(benzo-1,3-dioxol-5-yl)amino]-4-methoxycyclobut-3-ene-1,2-dione, C&lt;sub>12&lt;/sub>H&lt;sub>9&lt;/sub>NO&lt;sub>5&lt;/sub> (3), is a precursor to an antimycobacterial squaramide. Block-shaped crystals of a monoclinic form (3-I, space group P2&lt;sub>1&lt;/sub>/c, Z = 8, Z' = 2) and needle-shaped crystals of a triclinic form (3-II, space group P-1, Z = 4, Z' = 2) were found to crystallize concomitantly. In both crystal forms, R&lt;sub>2&lt;/sub>&lt;sup>2&lt;/sup>(10) dimers assemble through N-H...O=C hydrogen bonds. These dimers are formed from crystallographically unique molecules in 3-I, but exhibit crystallographic C&lt;sub>i&lt;/sub> symmetry in 3-II. Twinning by pseudomerohedry was encountered in the crystals of 3-II. The conformations of 3 in the solid forms 3-I and 3-II are different from one another</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-06-01T13:33:53.781Z</modification><creation>2024-11-09T01:56:41.181Z</creation></dates><accession>S-EPMC11299207</accession><cross_references><pubmed>38967633</pubmed><doi>10.1107/S2053229624006211</doi></cross_references></HashMap>